CTSD and breast cancer: LPMSNs and organosilica NPs seem good candidates for the delivery of pepstatin A (C34H63N5O9), a small hydrophobic pentapeptide which is the most potent inhibitor of cathepsin D, a lysosomal aspartic endopeptidase overexpressed in solid tumors and breast cancer [32].